— Know what they know.
Not Investment Advice

SYRE NASDAQ

Spyre Therapeutics, Inc.
1W: -1.8% 1M: +1.8% 3M: +72.0% YTD: +143.0% 1Y: +382.6% 3Y: +1892.5% 5Y: -60.7%
$74.05
-0.27 (-0.36%)
 
Weekly Expected Move ±7.0%
$64 $70 $75 $80 $85
NASDAQ · Healthcare · Biotechnology · Alpha Radar Buy · Power 55 · $4.5B mcap · 53M float · 2.10% daily turnover · Short 64% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
40.2 / 100
NoneWeakNarrowWide
Primary source: Switching Costs  ·  ROIC: 443.1%
Cost Advantage
45
Intangibles
33
Switching Cost
49
Network Effect
37
Scale
34
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. SYRE shows a Weak competitive edge (40.2/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Switching Costs. ROIC of 443.1% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$102
Low
$104
Avg Target
$107
High
Based on 2 analysts since May 5, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 11Hold: 0Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$88.64
Analysts11
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-12 Deutsche Bank $88 $102 +14 +34.4% $75.89
2026-05-06 Stifel Nicolaus Alex Thompson $71 $107 +36 +50.7% $71.01
2026-04-14 Robert W. Baird $50 $90 +40 +42.2% $63.27
2026-04-14 Wells Fargo $40 $90 +50 +42.2% $63.27
2026-04-14 Deutsche Bank $43 $88 +45 +39.1% $63.27
2026-04-13 Raymond James Initiated $80 +26.4% $63.27
2026-04-13 Wedbush David Nierengarten Initiated $80 +26.4% $63.27
2026-04-13 Leerink Partners Initiated $106 +67.5% $63.27
2026-04-13 BTIG Julian Harrison $40 $98 +58 +54.9% $63.26
2026-04-13 Jefferies Initiated $85 +31.2% $64.78
2026-03-16 William Blair Initiated $49 +12.1% $43.70
2025-12-17 Mizuho Securities Initiated $53 +60.3% $33.06
2025-09-26 Deutsche Bank Initiated $43 +164.8% $16.24
2024-11-12 Stifel Nicolaus Alex Thompson Initiated $71 +99.9% $35.52
2024-10-17 Robert W. Baird Colleen Kusy Initiated $50 +54.5% $32.37
2024-10-15 Wells Fargo Yanan Zhu Initiated $40 +30.5% $30.66
2024-05-10 BTIG Julian Harrison Initiated $40 +13.7% $35.19

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

D+
May 22, 2026
DCF
2
ROE
1
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. SYRE receives an overall rating of D+. Areas of concern: DCF (2/5), ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-04-22 C- D+
2026-04-10 D+ C-
2026-04-09 C- D+
2026-04-06 D+ C-
2026-04-02 C- D+
2026-03-02 D+ C-
2026-02-24 C- D+
2026-02-06 C C-
2026-01-03 C- C

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

Grade A+
Profitability
Balance Sheet
85
Earnings Quality
81
Growth
Value
32
Momentum
Safety
100
Cash Flow
41

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
165.78
Safe Zone
Piotroski F-Score
3/9
Beneish M-Score
Ohlson O-Score
-4.26
Bankruptcy prob: 1.4%
Low Risk
Credit Rating
AA
Score: 89.0/100
Trend: Stable
Earnings Quality
OCF/NI: 1.04x
Accruals: 0.9%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. SYRE scores 165.78, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. SYRE scores 3/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. SYRE's implied 1.4% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. SYRE receives an estimated rating of AA (score: 89.0/100), with a stable trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-142.81x
PEG
2.83x
P/S
49.43x
P/B
38.20x
P/FCF
-93.94x
P/OCF
EV/EBITDA
-82.96x
EV/Revenue
184.52x
EV/EBIT
-82.96x
EV/FCF
-89.87x
Earnings Yield
-1.03%
FCF Yield
-1.06%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. SYRE currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
0.891
EBT / EBIT
×
EBIT Margin
-2.224
EBIT / Rev
×
Asset Turnover
0.131
Rev / Assets
×
Equity Multiplier
1.124
Assets / Equity
=
ROE
-29.1%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. SYRE's ROE of -29.1% is driven by Asset Turnover (0.131), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$74.05
Median 1Y
$34.35
5th Pctile
$6.06
95th Pctile
$196.38
Ann. Volatility
112.4%
Analyst Target
$88.64
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Cameron Turtle
Chief Executive Officer
$665,000 $— $6,707,361
Sheldon Sloan Medical
edical Officer
$503,000 $— $2,211,805
Heidy King-Jones Legal
Legal Officer and Corporate Secretary
$490,000 $— $2,192,045
Scott Burrows Financial
ancial Officer
$490,000 $— $2,192,045

CEO Pay Ratio

14:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $6,707,361
Avg Employee Cost (SGA/emp): $469,696
Employees: 102

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
102
+56.9% YoY
Revenue / Employee
Profit / Employee
$-1,521,598
NI: $-155,203,000
SGA / Employee
$469,696
Avg labor cost proxy
R&D / Employee
$1,682,873
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -65.8% -68.1% -58.8% -64.4% -78.2% -76.4% -1.2% -1.2% -4.1% -4.4% -2.9% -3.1% -1.6% -1.8% -59.3% -59.5% -58.9% -42.5% -25.2% -29.1% -29.10%
ROA -53.8% -55.6% -48.5% -53.0% -64.5% -62.9% -92.6% -85.9% -3.0% -3.3% -1.6% -1.8% -90.1% -1.0% -43.8% -44.0% -43.5% -31.4% -22.4% -25.9% -25.89%
ROIC 52.4% 54.1% 12.6% 13.8% 16.8% 16.5% 86.2% 80.5% 219.6% 219.2% 1.2% 1.4% 79.5% 98.3% 1.9% 2.0% 2.0% 2.0% 4.0% 4.4% 4.43%
ROCE -45.3% -46.8% -73.1% -80.0% -97.4% -95.4% -1.5% -1.4% -1.5% -1.8% -41.4% -50.8% -55.8% -62.9% -37.6% -38.7% -40.1% -32.1% -24.9% -28.0% -27.99%
Gross Margin 0.9% -9.6% 86.2% 63.5% 24.0% -1.9% -1.9% -1.8% 1.0% 50.0%
Operating Margin -49.0% -14.5% -5.6% -17.9% -35.9% -107.8% -114.1% -95.0% -231.5% -63.2%
Net Margin -49.9% -14.5% -5.6% -17.9% -35.7% -104.8% -112.0% -93.0% -315.5% -69.1%
EBITDA Margin -46.0% -14.2% -5.5% -17.6% -34.9% -103.1% -108.9% -90.5% -41.2% -69.1%
FCF Margin -4.0% -3.5% -2.9% -3.0% -11.9% -14.0% -34.4% -61.4% -55.0% -82.6% -112.8% -161.1% -1.9% -2.1% -2.05%
OCF Margin -3.8% -3.4% -2.9% -3.0% -11.8% -14.0% -34.4% -61.4% -55.0% -82.6% -112.8% -161.1% -1.9% -2.1% -2.05%
ROE 3Y Avg snapshot only -87.79%
ROE 5Y Avg snapshot only -1.01%
ROA 3Y Avg snapshot only -54.65%
ROIC Economic snapshot only -25.65%
Cash ROA snapshot only -23.89%
NOPAT Margin snapshot only -2.02%
Pretax Margin snapshot only -1.98%
R&D / Revenue snapshot only 2.10%
SGA / Revenue snapshot only 56.57%
SBC / Revenue snapshot only 31.78%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -6.94 -7.68 -3.56 -2.11 -0.47 -0.58 -0.35 -0.35 -0.16 -0.18 -1.38 -3.80 -5.73 -6.96 -5.26 -4.66 -4.39 -6.80 -73.04 -97.27 -142.807
P/S Ratio 33.35 34.65 12.51 7.55 5.91 8.54 12.63 23.46 35.11 49.90 527.19 2012.97 125.27 192.88 49.426
P/B Ratio 3.27 3.74 2.79 1.81 0.49 0.59 0.58 0.54 0.86 1.05 2.54 7.53 5.79 8.13 2.11 1.88 1.75 1.96 15.85 24.40 38.199
P/FCF -8.43 -9.84 -4.32 -2.50 -0.50 -0.61 -0.37 -0.38 -0.64 -0.60 -4.68 -12.50 -6.81 -9.90 -6.96 -5.73 -5.89 -6.26 -66.98 -93.94 -93.942
P/OCF
EV/EBITDA -4.90 -5.75 -2.29 -0.91 0.54 0.46 0.26 0.31 0.10 -0.02 -1.00 -6.66 -4.20 -5.93 -2.36 -1.72 -1.38 -2.30 -59.03 -82.96 -82.955
EV/Revenue 23.07 25.32 7.81 3.17 -6.62 -6.64 -9.31 -20.38 -6.48 1.44 144.26 1519.84 116.91 184.52 184.520
EV/EBIT -4.80 -5.62 -2.23 -0.89 0.53 0.45 0.26 0.30 0.09 -0.02 -1.00 -6.64 -4.20 -5.93 -2.36 -1.72 -1.38 -2.30 -59.03 -82.96 -82.955
EV/FCF -5.83 -7.19 -2.70 -1.05 0.56 0.47 0.27 0.33 0.12 -0.02 -1.28 -9.44 -4.64 -7.65 -3.12 -2.18 -1.98 -2.53 -62.51 -89.87 -89.870
Earnings Yield -14.4% -13.0% -28.1% -47.4% -2.1% -1.7% -2.9% -2.8% -6.3% -5.6% -72.5% -26.3% -17.5% -14.4% -19.0% -21.5% -22.8% -14.7% -1.4% -1.0% -1.03%
FCF Yield -11.9% -10.2% -23.2% -39.9% -2.0% -1.6% -2.7% -2.6% -1.6% -1.7% -21.4% -8.0% -14.7% -10.1% -14.4% -17.5% -17.0% -16.0% -1.5% -1.1% -1.06%
PEG Ratio snapshot only 2.826
Price/Tangible Book snapshot only 24.404
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 9.11 9.11 4.91 4.91 4.91 4.91 4.25 4.25 4.25 4.25 10.68 10.68 10.68 10.68 11.26 11.26 11.26 11.26 13.25 13.25 13.253
Quick Ratio 9.11 9.11 4.91 4.91 4.91 4.91 4.25 4.25 4.25 4.25 10.68 10.68 10.68 10.68 11.26 11.26 11.26 11.26 13.25 13.25 13.253
Debt/Equity 0.04 0.04 0.06 0.06 0.06 0.06 0.09 0.09 0.09 0.09 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Net Debt/Equity -1.01 -1.01 -1.05 -1.05 -1.05 -1.05 -1.02 -1.02 -1.02 -1.02 -1.84 -1.84 -1.84 -1.84 -1.16 -1.16 -1.16 -1.16 -1.06 -1.06 -1.058
Debt/Assets 0.03 0.03 0.05 0.05 0.05 0.05 0.07 0.07 0.07 0.07 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Debt/EBITDA -0.08 -0.08 -0.08 -0.07 -0.06 -0.06 -0.06 -0.06 -0.06 -0.05 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.000
Net Debt/EBITDA 2.19 2.12 1.38 1.26 1.03 1.05 0.62 0.67 0.62 0.52 2.67 2.16 1.96 1.74 2.89 2.81 2.71 3.39 4.22 3.76 3.758
Interest Coverage
Equity Multiplier 1.16 1.16 1.31 1.31 1.31 1.31 1.41 1.41 1.41 1.41 1.86 1.86 1.86 1.86 1.18 1.18 1.18 1.18 1.09 1.09 1.087
Cash Ratio snapshot only 12.891
Defensive Interval snapshot only 1192.1 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.11 0.12 0.14 0.15 0.05 0.04 0.03 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.13 0.13 0.131
Inventory Turnover
Receivables Turnover 45.99 49.33 17.25 14.25 3.91 1.96 2.06 1.77 4.73 3.67 0.00 0.00
Payables Turnover 5.02 10.51 10.38 10.56 5.86 0.71 0.98 1.01 0.77 0.52 0.70 0.00 0.00 0.00 0.00 0.00 0.00 57.93 18.91 18.91 18.912
DSO 0 0 8 7 21 26 93 186 177 206 77 99 0 0 0.0 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 73 35 35 35 62 515 371 362 474 703 524 6 19 19 19.3 days
Cash Conversion Cycle -73 -35 -27 -27 -41 -489 -278 -176 -297 -497 -447 -19 -19 -19.3 days
Cash Velocity snapshot only 0.120
Capital Intensity snapshot only 8.595
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue -48.7% -61.5% -87.6% -94.2% -82.5% -81.8% -62.0% -40.9% -1.0% -1.0% -1.0% -1.0%
Net Income 20.9% 14.6% 18.7% 10.4% -33.0% -25.5% -27.4% -8.0% -2.1% -2.4% -3.0% -3.7% 31.8% 27.0% 38.6% 42.6% -11.2% 30.7% 25.4% 14.1% 14.12%
EPS 36.2% 19.2% 4.7% 10.9% -6.2% 12.3% 3.8% 24.4% -1.7% -2.0% 51.3% 51.7% 94.2% 93.8% 71.7% 65.2% 17.0% 41.6% 89.9% 85.0% 85.04%
FCF 31.1% 33.0% 32.2% 21.2% -53.9% -53.0% -47.7% -18.0% 19.0% -7.0% -24.6% -55.0% -1.3% -73.8% -57.6% -53.3% 1.4% -7.0% -7.5% -9.4% -9.38%
EBITDA 23.3% 16.8% 20.5% 11.9% -32.8% -25.9% -28.2% -8.5% 3.6% -16.9% -55.2% -1.1% -1.1% -99.5% -63.9% -36.4% -28.5% 8.8% 14.1% 6.1% 6.10%
Op. Income 22.2% 15.7% 19.4% 10.9% -33.1% -26.6% -29.1% -10.1% -1.5% -1.5% -1.9% -2.4% 27.7% 10.4% 13.9% 21.0% -35.8% -10.6% -0.5% -8.1% -8.06%
OCF Growth snapshot only -9.38%
Asset Growth snapshot only 27.82%
Equity Growth snapshot only 38.13%
Shares Change snapshot only 4.74%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 27.4% 41.1% 68.9% 1.0% 2.4% 3.3% 3.27%
Revenue 5Y 58.4% 43.0% 37.8% 33.4% 7.7% 3.2% -14.9% -27.3% -28.6% -27.8% -25.6% -22.0%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y
Gross Profit 5Y
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 42.3% 42.3% 12.2% 12.2% 12.2% 12.2% -5.1% -5.1% -5.1% -5.1% 28.4% 28.4% 28.4% 28.4% 76.9% 76.9% 76.9% 76.9% 1.2% 1.2% 1.22%
Assets 5Y 33.1% 33.1% 10.4% 10.4% 10.4% 10.4% 4.9% 4.9% 4.9% 4.9% 34.5% 34.5% 34.5% 34.5% 48.9% 48.9% 48.9% 48.9% 36.9% 36.9% 36.92%
Equity 3Y 40.6% 40.6% 7.6% 7.6% 7.6% 7.6% -5.7% -5.7% -5.7% -5.7% 9.6% 9.6% 9.6% 9.6% 83.4% 83.4% 83.4% 83.4% 1.4% 1.4% 1.42%
Book Value 3Y -4.5% -2.4% -14.3% -18.2% -20.8% -24.2% -25.3% -33.5% -22.6% -21.4% -48.1% -54.4% -57.6% -59.2% -36.3% -35.4% -30.6% -27.3% -52.5% -46.3% -46.29%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.21 0.21 0.21 0.20 0.17 0.13 0.05 0.03 0.01 0.00 0.00 0.00 0.03 0.04 0.05 0.05 0.05 0.05 0.41 0.41 0.410
Earnings Stability 0.85 0.84 0.76 0.80 0.81 0.78 0.67 0.61 0.61 0.57 0.51 0.47 0.58 0.59 0.49 0.46 0.55 0.35 0.29 0.31 0.311
Margin Stability 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.07 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Rev. Growth Consistency 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.500
Earn. Growth Consistency 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 1.00 1.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.92 0.94 0.93 0.96 0.87 0.90 0.89 0.97 0.50 0.50 0.50 0.50 0.87 0.89 0.85 0.83 0.96 0.88 0.90 0.94 0.944
Earnings Smoothness
ROE Trend 0.68 0.71 0.16 0.09 -0.11 -0.11 -0.98 -0.83 -4.66 -5.10 -0.62 -0.78 2.22 2.27 1.35 1.36 2.81 3.22 0.90 0.94 0.941
Gross Margin Trend 0.40 0.13 0.58 1.60
FCF Margin Trend -47.05 -73.79 -94.10 -128.87
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.79 0.76 0.82 0.84 0.95 0.95 0.96 0.92 0.25 0.30 0.29 0.30 0.84 0.70 0.76 0.81 0.75 1.09 1.09 1.04 1.035
FCF/OCF 1.04 1.03 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF/Net Income snapshot only 1.035
CapEx/Revenue 14.9% 10.4% 3.1% 0.8% 1.8% 0.7% 1.6% 0.1% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Accruals Ratio -0.11 -0.13 -0.09 -0.09 -0.03 -0.03 -0.04 -0.07 -2.27 -2.29 -1.16 -1.23 -0.14 -0.31 -0.11 -0.08 -0.11 0.03 0.02 0.01 0.009
Sloan Accruals snapshot only 0.238
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -5.4% -4.7% 0.0% 0.0% 0.0% -0.2% -0.4% -0.4% -0.2% 0.0% -36.2% -24.4% -31.7% -12.1% -21.6% -6.9% -7.5% -22.3% -2.8% -1.9% -1.87%
Total Shareholder Return -5.4% -4.7% 0.0% 0.0% 0.0% -0.2% -0.4% -0.4% -0.2% 0.0% -36.2% -24.4% -31.7% -12.1% -21.6% -6.9% -7.5% -22.3% -2.8% -1.9% -1.87%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 3.23 2.97 2.64 2.31 1.08 1.10 1.00 0.97 0.93 0.84 0.87 0.89 0.891
EBIT Margin -4.81 -4.50 -3.50 -3.57 -12.44 -14.75 -36.06 -66.95 -68.77 -94.16 -144.71 -228.97 -1.98 -2.22 -2.224
Asset Turnover 0.11 0.12 0.14 0.15 0.05 0.04 0.03 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.13 0.13 0.131
Equity Multiplier 1.22 1.22 1.21 1.21 1.21 1.21 1.35 1.35 1.35 1.35 1.76 1.76 1.76 1.76 1.35 1.35 1.35 1.35 1.12 1.12 1.124
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-25.06 $-25.87 $-33.33 $-27.28 $-26.61 $-22.68 $-32.06 $-20.63 $-71.30 $-68.57 $-15.61 $-9.98 $-4.10 $-4.22 $-4.42 $-3.47 $-3.41 $-2.47 $-0.45 $-0.52 $-0.52
Book Value/Share $53.26 $53.14 $42.52 $31.80 $25.53 $22.28 $19.24 $13.34 $13.16 $11.72 $8.48 $5.04 $4.06 $3.62 $11.01 $8.59 $8.53 $8.57 $2.07 $2.07 $1.94
Tangible Book/Share $53.26 $53.14 $42.52 $31.80 $25.53 $22.28 $19.24 $13.34 $13.16 $11.72 $8.48 $5.04 $4.06 $3.62 $11.01 $8.59 $8.53 $8.57 $2.07 $2.07 $2.07
Revenue/Share $5.22 $5.74 $9.49 $7.61 $2.14 $1.54 $0.89 $0.31 $0.32 $0.25 $0.04 $0.02 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.26 $0.26 $0.26
FCF/Share $-20.63 $-20.20 $-27.50 $-22.96 $-25.34 $-21.58 $-30.67 $-18.97 $-17.65 $-20.26 $-4.60 $-3.04 $-3.45 $-2.97 $-3.35 $-2.82 $-2.54 $-2.68 $-0.49 $-0.54 $-0.54
OCF/Share $-19.85 $-19.60 $-27.21 $-22.90 $-25.30 $-21.57 $-30.66 $-18.97 $-17.65 $-20.26 $-4.60 $-3.04 $-3.45 $-2.97 $-3.35 $-2.82 $-2.54 $-2.68 $-0.49 $-0.54 $-0.54
Cash/Share $55.72 $55.58 $47.17 $35.28 $28.32 $24.72 $21.31 $14.78 $14.57 $12.97 $15.63 $9.29 $7.49 $6.67 $12.82 $10.01 $9.94 $9.98 $2.19 $2.19 $2.14
EBITDA/Share $-24.55 $-25.25 $-32.40 $-26.53 $-26.03 $-22.20 $-31.37 $-20.15 $-21.58 $-22.78 $-5.86 $-4.30 $-3.82 $-3.83 $-4.43 $-3.56 $-3.66 $-2.95 $-0.52 $-0.58 $-0.58
Debt/Share $2.08 $2.07 $2.56 $1.92 $1.54 $1.34 $1.77 $1.23 $1.21 $1.08 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Net Debt/Share $-53.64 $-53.51 $-44.61 $-33.36 $-26.78 $-23.37 $-19.54 $-13.55 $-13.36 $-11.90 $-15.63 $-9.29 $-7.49 $-6.67 $-12.82 $-10.01 $-9.94 $-9.98 $-2.19 $-2.19 $-2.19
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 165.785
Altman Z-Prime snapshot only 292.624
Piotroski F-Score 5 5 4 2 2 2 1 1 2 1 2 2 3 3 3 3 3 2 3 3 3
Beneish M-Score -7.57 -2.15 1.52 -2.94 -16.97
Ohlson O-Score snapshot only -4.255
ROIC (Greenblatt) snapshot only -27.99%
Net-Net WC snapshot only $2.07
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only AA
Credit Score 74.02 73.71 45.50 42.18 42.88 43.26 44.51 44.63 44.29 44.50 64.16 74.63 70.45 74.51 89.00 89.00 89.00 89.00 89.00 89.00 89.000
Credit Grade snapshot only 3
Credit Trend snapshot only 0.000
Implied Spread (bps) snapshot only 80.000
Industry Credit Rank snapshot only 91
Sector Credit Rank snapshot only 87

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms